Mixed results for IO Biotech's cancer vaccine Cylembio thepharmaletter.com/biotechnology/…

FDA report on the state of pharmaceutical quality thepharmaletter.com/pharmaceutical…

Illuminating Castleman’s disease: advances in pharmacological treatments thepharmaletter.com/biotechnology/…

Sana Alajmovic to join Enzymatica AB Sweden as CEO thepharmaletter.com/pharmaceutical…

Trump’s proposed 200%-250% tariff on pharma imports to lead to drug shortages and higher prices thepharmaletter.com/pharmaceutical…

Bionova Scientific opens plasmid DNA facility in Texas thepharmaletter.com/biotechnology/…

Regulatory round-up: 11 August 2025 thepharmaletter.com/insights/regul…

Padcev plus Keytruda improves survival in bladder cancer patients thepharmaletter.com/biotechnology/…

As the FDA Goes AI-First, Biopharma Must Rethink Regulatory Operations thepharmaletter.com/pharmaceutical…

EU: Pharma tariffs impact on countries and companies will vary thepharmaletter.com/pharmaceutical…

FDA approves Brinsupri for chronic inflammatory lung condition thepharmaletter.com/pharmaceutical…

Biologics arm offsets softer discovery demand for Evotec in Q2 thepharmaletter.com/pharmaceutical…

AI tools could reshape idiopathic pulmonary fibrosis diagnosis and care thepharmaletter.com/pharmaceutical…

Administration pilot offers cautious reform to 340B rebate model thepharmaletter.com/pharmaceutical…

CRISPR-based therapeutics hold potential to combat AMR thepharmaletter.com/pharmaceutical…

Telitacicept hits Phase III goal for primary Sjögren's syndrome thepharmaletter.com/biotechnology/…

Response offers positive Phase II data for post-GLP-1 obesity thepharmaletter.com/pharmaceutical…

Nasus Pharma prices $10 million IPO thepharmaletter.com/pharmaceutical…

Ribopeutic secures pre-A funding to advance RNA drug discovery thepharmaletter.com/pharmaceutical…

Pilatus Biosciences teams up with Roche to evaluate PLT012 thepharmaletter.com/biotechnology/…